Angiographic and clinical outcomes of bivalirudin versus heparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention

BACKGROUND: Heparin with adjunctive glycoprotein IIb/IIIa platelet receptor (GP IIb/IIIa) inhibitors has demonstrated its effectiveness in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Bivalirudin, a direct thrombin inhibitor, has recently been show...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Matar, Fadi, Donoghue, Colleen, Rossi, Peter, Vandormael, Michel, Sullebarger, John T, Kerensky, Richard, Jauch, Werner, Gloer, Kathy, Ebra, George
Médium: Artigo
Jazyk:Inglês
Vydáno: Pulsus Group Inc 2006
Témata:
Clinical Studies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2569056/
https://ncbi.nlm.nih.gov/pubmed/17102832
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky